Back to results
US 2011/0033426 A1Published application
Use of modified cells for the treatment of multiple sclerosis
AssigneeUniversitaetsklinikum Hamburg-Eppendorf
InventorsRoland Martin, Andreas Lutterotti, Stephen Miller
Life of this patent
Estimating the term…
Abstract
The present invention describes blood cells chemically coupled with immunodominant myelin peptides and their use in the treatment of Multiple Sclerosis.
Claims14
A blood cell chemically coupled with a cocktail of at least five peptides selected from the following eight immunodominant myelin peptides:
- MBP 13-32, MBP 83-99, MBP 111-129, MBP 146-170, PLP 139-154, MOG 1-20, MOG 35-55 and MBP 82-98.
Dependencies are inferred from the claim text.